Fund Holdings — Lion Point Capital, LP

Total Portfolio Value
$14.73M
Total Bought
$189.3K
Total Sold
$1.90M
Net Transaction
-$1.71M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MILESTONE PHARMACEUTICALS IN(MIST)548,806548,80604391,0657.23%+626
FENNEC PHARMACEUTICALS INC(FENC)195,700195,70001,1921,62411.03%+432
KINIKSA PHARMACEUTICALS INTL(KNSA)45,90045,90001,0191,2708.62%+251
BRIDGEBIO PHARMA INC(BBIO)26,00026,00008991,1237.62%+224
SERES THERAPEUTICS INC(MCRB)017,038+17,03801891.29%+189
JASPER THERAPEUTICS INC(JSPR)146,500146,50006308135.52%+183
AVADEL PHARMACEUTICALS PLC98,70098,70007738735.93%+101
REGENXBIO INC(RGNX)57,75057,75004134743.22%+61
DISC MEDICINE INC(IRON)10,60010,60005265613.81%+35
HUMACYTE INC(HUMA)83,50083,50001421751.18%+32
SPRUCE BIOSCIENCES INC75,0000-75,000220—-22
MERSANA THERAPEUTICS INC644,000644,00002221911.29%-31
ARCUTIS BIOTHERAPEUTICS INC(ARQT)46,30046,30007246494.41%-75
BENITEC BIOPHARMA INC(BNTC)62,00062,00008077254.93%-81
GERON CORP(GERN)500,000500,00007957054.79%-90
SYNDAX PHARMACEUTICALS INC(SNDX)55,00055,00006765153.50%-161
MINERALYS THERAPEUTICS INC(MLYS)79,00079,00001,2551,0697.26%-186
BIOHAVEN LTD(BHVN)22,70022,70005463202.17%-225
SERES THERAPEUTICS INC(MCRB)340,7610-340,7612390—-239
ARDELYX INC335,400335,40001,6471,3158.93%-332
BLUEBIRD BIO INC78,9120-78,9123850—-385
INSMED INC(INSM)30,50010,650-19,8502,3271,0727.28%-1,255
Page 1 of 1
Lion Point Capital, LP — 13F Holdings — Q2 2025 | TickerTrail